Discovery of micromolar PDE IV inhibitors that exhibit much reduced affinity for the [3H]rolipram binding site: 3-norbornyloxy-4-methoxyphenylmethylene oxindoles
Authors:
- 7 September 1995
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 5 (17) , 1965-1968
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Anti‐inflammatory and bronchodilator properties of RP 73401, a novel and selective phosphodiesterase type IV inhibitorBritish Journal of Pharmacology, 1994
- Structure-activity relationships involving the catechol subunit of rolipramBioorganic & Medicinal Chemistry Letters, 1994
- Selective Type IV Phosphodiesterase Inhibitors as Antiasthmatic Agents. The Syntheses and Biological Activities of 3-(Cyclopentyloxy)-4-methoxybenzamides and AnalogsJournal of Medicinal Chemistry, 1994
- Theophylline in the management of asthma: time for reappraisal?European Respiratory Journal, 1994
- Inhibitors of Cyclic Nucleotide Phosphodiesterase Isoenzymes—their Potential Utility in the Therapy of AsthmaPulmonary Pharmacology, 1994
- Substituted 1,8-Naphthyridin-2(1H)-ones as Selective Phosphodiesterase IV Inhibitors.Biological and Pharmaceutical Bulletin, 1994
- Prospects for selective cyclic nucleotide phosphodiesterase inhibitors in the treatment of bronchial asthmaClinical & Experimental Allergy, 1992
- Differential modulation of tissue function and therapeutic potential of selective inhibitors of cyclic nucleotide phosphodiesterase isoenzymesTrends in Pharmacological Sciences, 1991
- Calcium-independent phosphodiesterase inhibitors as putative antidepressants: [3-(bicycloalkyloxy)-4-methoxyphenyl-2-imidazolidinonesJournal of Medicinal Chemistry, 1991
- Primary sequence of cyclic nucleotide phosphodiesterase isozymes and the design of selective inhibitorsTrends in Pharmacological Sciences, 1990